Le Lézard
Classified in: Health
Subject: FDA

Trovita Health Science Announces FDA Marketing Clearance of New SAFE-T FEEDtm Nutrition Delivery Device for Tube Feeding


PHILADELPHIA, March 20, 2017 /PRNewswire/ -- Trovita Health Science, an emerging life science company specializing in medical nutrition, announces U.S. Food and Drug Administration marketing authorization of the new SAFE-T FEEDtm device for administering tube feeding formulas. The nutrition delivery device is a novel, ready-to-feed pouch offering the first and only fully-closed system, pre-packaged with complete enteral formulas.

SAFE-T FEED simplifies the tube feeding process from over sixty steps to just seven, and eliminates pouring enteral formulas into an open syringe or gravity bag for feedings. This is important because a recent survey of 250 tube feeding patients and caregivers noted that 76% of patients experienced not meeting their daily nutrition requirements due to problems with their equipment or formulas. Malnutrition resulting from improper tube feeding may lead to increased healthcare costs due to hospital re-admissions and added physician visits. 

SAFE-T FEED incorporates the new ENFit® nutrition connector, while also featuring a cap-less "No Spill" spout.  The patent-pending, leak-proof connector allows SAFE-T FEED to be disconnected from a tube in the midst of a feeding and stored for later use. Trovita successfully demonstrated SAFE-T FEED achieved high flow rates when tested with high viscosity formulas, allowing for a wide range of enteral nutrition formulas to be pre-filled inside the disposable delivery device.

Along with the new delivery device, Trovita Health Science will launch Ultrient® Ready-to-Feed, a new line of tube feeding formulas to be pre-packaged inside SAFE-T FEED for easy tube feeding.  The new formulas will offer superior ingredients from real food sources, and low sugar levels consistent with the FDA and American Heart Association recommendation to limit daily sugar consumption. Trovita's Ultrient Ready-to-Feed formulas will be the only enteral formulas available with SAFE-T FEED.

"The FDA marketing clearance of SAFE-T FEED is a significant advancement toward improving the quality of health care for people who require tube feeding," noted Will Brown, Trovita's CEO. "Simultaneously advancing both the quality of nutrition with Ultrient Ready-to-Feed formulas, and offering a simplified administration device with SAFE-T FEED is a major step toward eliminating unintended malnutrition with enteral feeding. Trovita Health Science will make a positive impact on the lives of tube feeding patients and their families, and we intend to help reduce downstream healthcare costs in the process."

About Trovita Health Science

Trovita Health Science is an emerging life science company specializing in medical nutrition innovation, with a focus on developing a portfolio of medical nutrition formulas and delivery devices.  Trovita currently markets ENU® Complete Nutrition Shakes. Trovita anticipates making the new Ultrient Ready-to-Feed formulas available in the SAFE-T FEED Pouch in 2017. Trovita is a member of GEDSA (Global Enteral Device Supplier Association).

TROVITA HEALTH SCIENCE
William Brown, CEO
Email: [email protected]
Phone: 855-266-6733

Related Links:

http://www.Ultrient.com

http://www.enu-nutrition.com 
http://www.TrovitaHealth.com 
http://stayconnected.org

 

SOURCE Trovita Health Science


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: